Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Medina

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 21, 2025
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registryMaria Gonzalez-Cao, Miguel-Ángel Berciano-Guerrero, Eva Muñoz-Couselo, et al.
Melanoma Research|September 3, 2025
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 studyPablo Cerezuela-Fuentes, Carlos Aguado de la Rosa, Guillermo Crespo, et al.
Melanoma Research|March 29, 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational studyJosé L Manzano, Juan Martin-Liberal, Luis A Fernández-Morales, et al.
Medicine|February 1, 2018
Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization studySalvador Martín Algarra, Virtudes Soriano, Luis Fernández-Morales, et al.
Cancer|July 7, 2026
Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 studyMiguel-Ángel Berciano-Guerrero, Elisabeth Pérez-Ruiz, Ainara Soria, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 28, 2025
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801Enrique Espinosa, Miguel-Ángel Berciano-Guerrero, Eva Muñoz-Couselo, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 21, 2025
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registryMaria Gonzalez-Cao, Miguel-Ángel Berciano-Guerrero, Eva Muñoz-Couselo, et al.
Melanoma Research|September 3, 2025
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 studyPablo Cerezuela-Fuentes, Carlos Aguado de la Rosa, Guillermo Crespo, et al.
Melanoma Research|March 29, 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational studyJosé L Manzano, Juan Martin-Liberal, Luis A Fernández-Morales, et al.
Medicine|February 1, 2018
Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization studySalvador Martín Algarra, Virtudes Soriano, Luis Fernández-Morales, et al.
Cancer|July 7, 2026
Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 studyMiguel-Ángel Berciano-Guerrero, Elisabeth Pérez-Ruiz, Ainara Soria, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 28, 2025
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801Enrique Espinosa, Miguel-Ángel Berciano-Guerrero, Eva Muñoz-Couselo, et al.
Pageof 11